Stock 688265 SHANGHAI MODEL ORGANISMS CENTER, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Model Organisms Center, Inc.

Equities

688265

CNE1000055L1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 24/06/2024 BST 		5-day change 1st Jan Change
20.78 CNY +0.73% Intraday chart for Shanghai Model Organisms Center, Inc. -4.55% -45.96%
04-29 Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-02 Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024. CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 5,461 3,820 2,998
Enterprise Value (EV) 1 3,811 2,810 2,068
P/E ratio 67.4 x -700 x -148 x
Yield 0.37% - 0.34%
Capitalization / Revenue 19.8 x 12.6 x 8.18 x
EV / Revenue 13.8 x 9.28 x 5.64 x
EV / EBITDA 54 x -112 x -86.7 x
EV / FCF 74.2 x -10.1 x -21.1 x
FCF Yield 1.35% -9.88% -4.74%
Price to Book 3.06 x 2.16 x 1.72 x
Nbr of stocks (in thousands) 77,964 77,964 77,964
Reference price 2 70.05 49.00 38.45
Announcement Date 28/04/22 28/04/23 29/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 121.4 154.8 196.2 275.3 303 366.5
EBITDA 1 8.697 18.22 46.63 70.51 -25.19 -23.86
EBIT 1 1.871 11.38 40.01 58.17 -43.44 -47.04
Operating Margin 1.54% 7.35% 20.39% 21.13% -14.34% -12.83%
Earnings before Tax (EBT) 1 15.99 24.34 48.88 69.07 -14.71 -29.9
Net income 1 15.11 23.25 44.56 60.86 -5.4 -20.58
Net margin 12.44% 15.02% 22.71% 22.11% -1.78% -5.62%
EPS 2 0.2900 0.4400 0.7800 1.040 -0.0700 -0.2600
Free Cash Flow 1 -1.94 21.9 -61.44 51.37 -277.6 -98.04
FCF margin -1.6% 14.15% -31.32% 18.66% -91.63% -26.75%
FCF Conversion (EBITDA) - 120.16% - 72.85% - -
FCF Conversion (Net income) - 94.18% - 84.4% - -
Dividend per Share - - - 0.2570 - 0.1300
Announcement Date 18/12/20 18/12/20 08/12/21 28/04/22 28/04/23 29/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 73.1 108 142 1,650 1,010 930
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1.94 21.9 -61.4 51.4 -278 -98
ROE (net income / shareholders' equity) 14.5% 18.8% 22.8% 5.97% -0.3% -1.18%
ROA (Net income/ Total Assets) 0.63% 3.47% 8.69% 3.13% -1.35% -1.45%
Assets 1 2,393 670.8 512.9 1,943 399.5 1,418
Book Value Per Share 2 2.150 2.320 4.360 22.90 22.70 22.40
Cash Flow per Share 2 1.000 0.3300 1.220 20.10 4.720 1.260
Capex 1 2.49 2.16 103 52.4 270 124
Capex / Sales 2.05% 1.4% 52.48% 19.02% 89.2% 33.91%
Announcement Date 18/12/20 18/12/20 08/12/21 28/04/22 28/04/23 29/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
SHANGHAI MODEL ORGANISMS CENTER, INC. Stock Shanghai Model Organisms Center, Inc.
-45.96% 220M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-18.17% 8.53B
RADNET, INC. Stock RadNet, Inc.
+65.89% 4.26B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+6.56% 2.71B
SYNLAB AG Stock SYNLAB AG
-1.93% 2.63B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-57.14% 1.72B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-19.16% 1.67B
FLEURY S.A. Stock Fleury S.A.
-20.01% 1.45B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+15.38% 1.19B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-50.40% 1.01B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. 688265 Stock
  4. Financials Shanghai Model Organisms Center, Inc.